Conditions: Human Immunodeficiency Virus (HIV) Vitamin D Deficiency HIV Infections
Keywords: Vitamin D Human Immunodeficiency Virus (HIV) Complementary Therapies
Allocation: RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 45
Healthy volunteers: no

Brief summary:
The purpose of this study is to evaluate how Vitamin D affects endothelial function, inflammation, lipids, insulin resistance, vitamin D levels, and parathyroid hormone (PTH).

Detailed description:
Randomized placebo controlled trial of vitamin D supplementation in HIV infected subjects with vitamin D deficiency

Arms:
arm 1: Participants that have been randomized into this arm will receive placebo pills. arm 2: Participants that have been randomized into this arm will receive Vitamin D 4000 IU (International Units) daily.

Interventions: intervention 1: Vitamin D intervention 2: Placebo
Intervention descriptions: intervention 1: Vitamin D 4000 IU will be administered to enrollees on the active comparator arm intervention 2: Placebo pills will be administered to enrollees in this arm

Protocol document: